Correlation Between Acumen Pharmaceuticals and 03027XBM1

Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and 03027XBM1 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and 03027XBM1 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acumen Pharmaceuticals and AMT 27 15 APR 31, you can compare the effects of market volatilities on Acumen Pharmaceuticals and 03027XBM1 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of 03027XBM1. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and 03027XBM1.

Diversification Opportunities for Acumen Pharmaceuticals and 03027XBM1

-0.37

Correlation Coefficient

Acumen Pharmaceuticals  03027XBM1

Very good diversification

The 3 months correlation between Acumen and 03027XBM1 is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and AMT 27 15 APR 31 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AMT 27 15 and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with 03027XBM1. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AMT 27 15 has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and 03027XBM1 go up and down completely randomly.

Pair Corralation between Acumen Pharmaceuticals and 03027XBM1

Given the investment horizon of 90 days Acumen Pharmaceuticals is expected to under-perform the 03027XBM1. In addition to that, Acumen Pharmaceuticals is 4.9 times more volatile than AMT 27 15 APR 31. It trades about -0.15 of its total potential returns per unit of risk. AMT 27 15 APR 31 is currently generating about -0.06 per unit of volatility. If you would invest  8,655  in AMT 27 15 APR 31 on December 24, 2024 and sell it today you would lose (271.00) from holding AMT 27 15 APR 31 or give up 3.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Acumen Pharmaceuticals  vs.  AMT 27 15 APR 31

Acumen Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Acumen Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

AMT 27 15

Risk-Adjusted Performance

Very Weak

Over the last 90 days AMT 27 15 APR 31 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 03027XBM1 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Acumen Pharmaceuticals and 03027XBM1

The main advantage of trading using opposite Acumen Pharmaceuticals and 03027XBM1 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, 03027XBM1 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 03027XBM1 will offset losses from the drop in 03027XBM1's long position.

The idea behind Acumen Pharmaceuticals and AMT 27 15 APR 31 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.